Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMpower130: Atezolizumab + Chemo in Stage IV Non-Squamous NSCLC
NCT02367781Phase 3Completed
- Sponsor
- Roche
- Start
- Apr 2015
- Primary completion
- Mar 2018
- Modality
- Monoclonal Antibodies
- Countries
- 8
01
Overview
A Phase 3 trial of atezolizumab in Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC), sponsored by Roche. Started Apr 2015; status: completed.
02
Drugs
atezolizumab
03
Conditions
Nonsquamous Non-Small Cell Lung Cancer (nsNSCLC)
Beyond the preview
Go deeper on NCT02367781.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02367781.